A rapid method for obtaining mesenchymal stem cells and platelets from bone marrow aspirate

Barbara Dozza, Giuliana Gobbi, Enrico Lucarelli, Michela Pierini, Claudia Di Bella, Tommaso Frisoni, Pier Luigi Tazzari, Francesca Ricci, Prisco Mirandola, Cecilia Carubbi, Sandro Giannini, Davide Donati, Marco Vitale

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) are currently used alone or in combination for therapeutic applications especially for bone repair. We tested whether MSCs can be isolated from bone marrow (BM) aspirate using a commercially available kit commonly used to obtain PRP from peripheral blood (PB). Results revealed that mononuclear cells and platelets from both PB and BM could be efficiently isolated by obtaining a mononuclear and platelet rich fraction (PB-MPRF and BM-MPRF, respectively). Starting with comparable volumes, the number of platelets increased 1.5-fold in BM-MPRF compared to PB-MPRF. The number of clonogenic cells in BM-MPRF samples was significantly higher than whole BM samples as revealed by CFU-F assay (54.92±8.55CFU-F/1.5 x 105 nucleated cells and 32.50±12.43CFU-F/1.5 x 105 nucleated cells, respectively). Cells isolated from BM-MPRF after in vitro expansion fulfilled the definition of MSCs by phenotypic criteria, and differentiated along osteogenic, adipogenic and chondrogenic lineages following induction. Results showed that the kit isolated MSCs and platelets from BM aspirate. Isolated MSCs were further expanded in a laboratory and BM-MPRF was used clinically following BM withdrawal for rapid intra-operative cell therapy for the treatment of bone defects.

Original languageEnglish
Pages (from-to)483-492
Number of pages10
JournalJournal of Tissue Engineering and Regenerative Medicine
Volume8
Issue number6
DOIs
Publication statusPublished - Jun 1 2014

Fingerprint

Platelets
Stem cells
Mesenchymal Stromal Cells
Bone
Blood Platelets
Bone Marrow
Platelet-Rich Plasma
Blood
Bone Marrow Cells
Bone and Bones
Cell- and Tissue-Based Therapy
Platelet Count
Plasmas
Assays
Repair
Therapeutics
Defects

Keywords

  • Bone marrow aspirate
  • Mesenchymal stem cells
  • Osteocompetent cells
  • Platelet-rich plasma
  • Platelets

ASJC Scopus subject areas

  • Biomedical Engineering
  • Medicine (miscellaneous)
  • Biomaterials
  • Medicine(all)

Cite this

A rapid method for obtaining mesenchymal stem cells and platelets from bone marrow aspirate. / Dozza, Barbara; Gobbi, Giuliana; Lucarelli, Enrico; Pierini, Michela; Bella, Claudia Di; Frisoni, Tommaso; Tazzari, Pier Luigi; Ricci, Francesca; Mirandola, Prisco; Carubbi, Cecilia; Giannini, Sandro; Donati, Davide; Vitale, Marco.

In: Journal of Tissue Engineering and Regenerative Medicine, Vol. 8, No. 6, 01.06.2014, p. 483-492.

Research output: Contribution to journalArticle

Dozza, B, Gobbi, G, Lucarelli, E, Pierini, M, Bella, CD, Frisoni, T, Tazzari, PL, Ricci, F, Mirandola, P, Carubbi, C, Giannini, S, Donati, D & Vitale, M 2014, 'A rapid method for obtaining mesenchymal stem cells and platelets from bone marrow aspirate', Journal of Tissue Engineering and Regenerative Medicine, vol. 8, no. 6, pp. 483-492. https://doi.org/10.1002/term.1551
Dozza, Barbara ; Gobbi, Giuliana ; Lucarelli, Enrico ; Pierini, Michela ; Bella, Claudia Di ; Frisoni, Tommaso ; Tazzari, Pier Luigi ; Ricci, Francesca ; Mirandola, Prisco ; Carubbi, Cecilia ; Giannini, Sandro ; Donati, Davide ; Vitale, Marco. / A rapid method for obtaining mesenchymal stem cells and platelets from bone marrow aspirate. In: Journal of Tissue Engineering and Regenerative Medicine. 2014 ; Vol. 8, No. 6. pp. 483-492.
@article{a764d4211bf542aabb6ecaa1f5bda21e,
title = "A rapid method for obtaining mesenchymal stem cells and platelets from bone marrow aspirate",
abstract = "Mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) are currently used alone or in combination for therapeutic applications especially for bone repair. We tested whether MSCs can be isolated from bone marrow (BM) aspirate using a commercially available kit commonly used to obtain PRP from peripheral blood (PB). Results revealed that mononuclear cells and platelets from both PB and BM could be efficiently isolated by obtaining a mononuclear and platelet rich fraction (PB-MPRF and BM-MPRF, respectively). Starting with comparable volumes, the number of platelets increased 1.5-fold in BM-MPRF compared to PB-MPRF. The number of clonogenic cells in BM-MPRF samples was significantly higher than whole BM samples as revealed by CFU-F assay (54.92±8.55CFU-F/1.5 x 105 nucleated cells and 32.50±12.43CFU-F/1.5 x 105 nucleated cells, respectively). Cells isolated from BM-MPRF after in vitro expansion fulfilled the definition of MSCs by phenotypic criteria, and differentiated along osteogenic, adipogenic and chondrogenic lineages following induction. Results showed that the kit isolated MSCs and platelets from BM aspirate. Isolated MSCs were further expanded in a laboratory and BM-MPRF was used clinically following BM withdrawal for rapid intra-operative cell therapy for the treatment of bone defects.",
keywords = "Bone marrow aspirate, Mesenchymal stem cells, Osteocompetent cells, Platelet-rich plasma, Platelets",
author = "Barbara Dozza and Giuliana Gobbi and Enrico Lucarelli and Michela Pierini and Bella, {Claudia Di} and Tommaso Frisoni and Tazzari, {Pier Luigi} and Francesca Ricci and Prisco Mirandola and Cecilia Carubbi and Sandro Giannini and Davide Donati and Marco Vitale",
year = "2014",
month = "6",
day = "1",
doi = "10.1002/term.1551",
language = "English",
volume = "8",
pages = "483--492",
journal = "Journal of Tissue Engineering and Regenerative Medicine",
issn = "1932-6254",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - A rapid method for obtaining mesenchymal stem cells and platelets from bone marrow aspirate

AU - Dozza, Barbara

AU - Gobbi, Giuliana

AU - Lucarelli, Enrico

AU - Pierini, Michela

AU - Bella, Claudia Di

AU - Frisoni, Tommaso

AU - Tazzari, Pier Luigi

AU - Ricci, Francesca

AU - Mirandola, Prisco

AU - Carubbi, Cecilia

AU - Giannini, Sandro

AU - Donati, Davide

AU - Vitale, Marco

PY - 2014/6/1

Y1 - 2014/6/1

N2 - Mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) are currently used alone or in combination for therapeutic applications especially for bone repair. We tested whether MSCs can be isolated from bone marrow (BM) aspirate using a commercially available kit commonly used to obtain PRP from peripheral blood (PB). Results revealed that mononuclear cells and platelets from both PB and BM could be efficiently isolated by obtaining a mononuclear and platelet rich fraction (PB-MPRF and BM-MPRF, respectively). Starting with comparable volumes, the number of platelets increased 1.5-fold in BM-MPRF compared to PB-MPRF. The number of clonogenic cells in BM-MPRF samples was significantly higher than whole BM samples as revealed by CFU-F assay (54.92±8.55CFU-F/1.5 x 105 nucleated cells and 32.50±12.43CFU-F/1.5 x 105 nucleated cells, respectively). Cells isolated from BM-MPRF after in vitro expansion fulfilled the definition of MSCs by phenotypic criteria, and differentiated along osteogenic, adipogenic and chondrogenic lineages following induction. Results showed that the kit isolated MSCs and platelets from BM aspirate. Isolated MSCs were further expanded in a laboratory and BM-MPRF was used clinically following BM withdrawal for rapid intra-operative cell therapy for the treatment of bone defects.

AB - Mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) are currently used alone or in combination for therapeutic applications especially for bone repair. We tested whether MSCs can be isolated from bone marrow (BM) aspirate using a commercially available kit commonly used to obtain PRP from peripheral blood (PB). Results revealed that mononuclear cells and platelets from both PB and BM could be efficiently isolated by obtaining a mononuclear and platelet rich fraction (PB-MPRF and BM-MPRF, respectively). Starting with comparable volumes, the number of platelets increased 1.5-fold in BM-MPRF compared to PB-MPRF. The number of clonogenic cells in BM-MPRF samples was significantly higher than whole BM samples as revealed by CFU-F assay (54.92±8.55CFU-F/1.5 x 105 nucleated cells and 32.50±12.43CFU-F/1.5 x 105 nucleated cells, respectively). Cells isolated from BM-MPRF after in vitro expansion fulfilled the definition of MSCs by phenotypic criteria, and differentiated along osteogenic, adipogenic and chondrogenic lineages following induction. Results showed that the kit isolated MSCs and platelets from BM aspirate. Isolated MSCs were further expanded in a laboratory and BM-MPRF was used clinically following BM withdrawal for rapid intra-operative cell therapy for the treatment of bone defects.

KW - Bone marrow aspirate

KW - Mesenchymal stem cells

KW - Osteocompetent cells

KW - Platelet-rich plasma

KW - Platelets

UR - http://www.scopus.com/inward/record.url?scp=84922480269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922480269&partnerID=8YFLogxK

U2 - 10.1002/term.1551

DO - 10.1002/term.1551

M3 - Article

C2 - 22715158

AN - SCOPUS:84922480269

VL - 8

SP - 483

EP - 492

JO - Journal of Tissue Engineering and Regenerative Medicine

JF - Journal of Tissue Engineering and Regenerative Medicine

SN - 1932-6254

IS - 6

ER -